The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis

V. A.S.H. Dalm, P. M. van Hagen, E. P. Krenning*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

26 Citations (Scopus)


Somatostatin receptors are widely expressed on cells and tissues throughout the human body. Apart from their expression in the physiological target organs of the peptide, somatostatin receptors are also expressed in various tumours. Ihe expression of somatostatin receptors on neuroendocrine tumours led to the development of somatostatin receptor scintigraphy using [111In-DTPA-D-Phe1]-octreotide (111In-pentetreotide) in order to visualize somatostatin receptor positive tumours and their metastases in vivo. Previous studies reported the expression of somatostatin receptors in both normal and pathological cells and tissues of the human immune system as well. Somatostatin receptors have been demonstrated in Hodgkin's and non-Hodgkin's lymphomas and sst scintigraphy has shown to be a useful tool in diagnosis and staging of these diseases. Moreover, sst expression has also been detected in granulomateus diseases, like sarcoidosis and auto-immune diseases, like rheumatoid arthritis. In this paper we discuss the (possible) role of somatostatin receptor scintigraphy in diagnosis, staging or follow-up of patients suffering from sarcoidosis and rheumatoid arthritis.

Original languageEnglish
Pages (from-to)270-278
Number of pages9
JournalQuarterly Journal of Nuclear Medicine
Issue number4
Publication statusPublished - Dec 2003

Bibliographical note



Dive into the research topics of 'The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis'. Together they form a unique fingerprint.

Cite this